Fracture Risk Up With Insulin Compared With Metformin in T2DM
Risk for major osteoporotic fractures up for insulin versus metformin for those with HbA1c <7 percent, BMI <25 kg/m2
Risk for major osteoporotic fractures up for insulin versus metformin for those with HbA1c <7 percent, BMI <25 kg/m2
Author reviews calciphylaxis incidence, risk factors, pathogenesis, differential diagnoses, and treatment.
The AHA released a statement focusing on the importance of managing cardiovascular risk factors in patients with type 2 diabetes.
Chronic kidney disease increases the risk of cardiovascular events associated with type 2 diabetes. A clinical trial sought to discover if finerenone would help patients with both of these conditions.
Using certain glucose inhibitors in people with type 2 diabetes may also have a beneficial effect on renal and cardiovascular health, and weight.
Greater reduction in glycated hemoglobin levels and improved weight loss seen with tirzepatide in type 2 diabetes
A team of investigators assessed the frequency with which patients with type 2 diabetes and heart failure were prescribed sodium-glucose co-transporter 2 inhibitors.
A team of investigators sought to identify the impact of hyperglycemia on the severity of and outcomes associated with stroke in patients with type 2 diabetes.
Researchers report the results of a systematic review assessing risk factors for peripheral artery disease in populations with type 2 diabetes.
Researchers sought to determine whether ertugliflozin plus insulin would help redice body weight, systolic blood pressure, HbA1c, and other metrics among individuals with T2DM.